Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like
Shumei Wang, Vickie Tsui, Terry D Crawford, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)
Terry D Crawford, James E Audia, Steve Bellon, et al.
Journal of Medicinal Chemistry
|
May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Nature Chemical Biology
|
May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
The Journal of Biological Chemistry
|
April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)
Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Journal of Medicinal Chemistry
|
September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like
Shumei Wang, Vickie Tsui, Terry D Crawford, et al.
ACS Medicinal Chemistry Letters
|
July 26, 2017
GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2)
Terry D Crawford, James E Audia, Steve Bellon, et al.
Journal of Medicinal Chemistry
|
May 25, 2016
Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains
Terry D Crawford, Vickie Tsui, E Megan Flynn, et al.
Nature Chemical Biology
|
May 24, 2016
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova, Victor S Gehling, Amy Gustafson, et al.
The Journal of Biological Chemistry
|
April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
ACS Medicinal Chemistry Letters
|
May 19, 2016
Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637)
Alexander M Taylor, Alexandre Côté, Michael C Hewitt, et al.
Journal of Medicinal Chemistry
|
September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Page
of 4